X

Trial Profile

POSITIVE: POSt-authorization drug Intensive surveillance monitoring sTudy of IVabradine efficacy and safety in patients with chronic heart failurE

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Jun 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ivabradine (Primary)
Indications Chronic heart failure
Focus Therapeutic Use
Acronyms POSITIVE
Sponsors Servier

Most Recent Events

08 Dec 2021 Results (N=655) of an interim analysis published in the American Journal of Cardiovascular Drugs
01 Jul 2021 Status changed from active, no longer recruiting to completed.
09 Jun 2021 Status changed from completed to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com